Return to Search
Medicare Benefit Policy Manual Chapter 8 - Coverage of Extended Care (SNF) Services Under Hospital Insurance Crosswalk
Guidance for 200.1 - Nesiritide for Treatment of Heart Failure Patients (Effective March 2, 2006) 200.2 - Nebulized Beta Adrenergic Agonist Therapy for Lung Diseases - (Effective September 10, 2007)
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: January 01, 2020
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.